HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Top Beauty Firms’ ‘Oil-Free’ Cosmetic Claims Targeted In US Courts

Executive Summary

Proposed class action plaintiffs against L’Oreal USA, Johnson & Johnson Consumer and E.l.f. Cosmetics allege that “oil-free” claims are false and misleading when applied to products containing dimethicone, tocopheryl acetate, jojoba esters and/or other members of chemical functional groups constituting oil.

You may also be interested in...



Target Corporation Settles ‘Oil-Free’ Cosmetic Suit; Walmart And L’Oreal Next In Line

Putative class actions filed in recent years against leading beauty companies and retailers for alleged false and misleading “oil-free” claims on cosmetic products appear to be drawing to a close, more often than not via undisclosed settlements.

US Plaintiffs Branching From Natural To Clean-Type Claims, Attorneys Warn At PCPC Virtual Summit

Are botanical claims equivalent to natural claims? Can hair truly be repaired? What constitutes “oil-free”? Such are the questions raised in growing litigation against cosmetic product companies under consumer protection statutes around the US, Conkle, Kremer & Engel attorneys say.

Too Small A Company To Interest US Plaintiffs’ Class Action Bar? Think Again, Attorney Says

Locke Lord, LLP senior counsel Sharon Blinkoff shares perspective from her experience defending smaller cosmetics companies against US class action plaintiff demands and litigation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150851

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel